W Health Ventures set to close $100 mn fund II for early-stage healthcare bets in India and US
Bengaluru: Delhi -based venture capital, W Health Ventures, will announce the first closing of the second fund of $ 100 million in the coming weeks, according to two people who are aware of development. The new fund will double in India and US companies in early health investments.
The new Fund will continue to support the initiatives in seed and A series stages with a check-up of $ 1 million-$ 5 million and will participate in larger tours with joint investors.
“W Health is at a very important stage in the growth of W Health Ventures. We are currently raising the Fund II and we will share updates about the donation collection and key leadership appointments in the coming weeks.” He said.
W Health’s new fund is a positive development for funding funding, as Tracxn decreased to $ 3 billion in 2024.
The company will also make its B series investments “selectively” by emphasizing health services built for both domestic and global markets. “The upcoming fund will continue to focus on early health innovation. In addition, we will selectively support A and B companies that are compatible with our thesis.”
“Our basic thesis continues to be consistent: to build generation health companies and beyond India. The model of creation of a company is a mixture of investing and incubating in companies through the venture studio.
Founded in 2019 by Sunil Wadhwani, the company mostly supports single private health service delivery and AI special services.
Diabetes Management Platform Wysa Health in Indian portfolio, health -oriented Venture Studio 2070 Health and Sexual Health and Healthy Life Provider Good Health Company. In the US, the mental health initiative led by AI supported seven companies including WYSA and Cancer support program Jasper.
Senior exit
Meanwhile, the manager of the company Namit Chugh, according to two people quoted above, resigned from the post and currently serves the notification.
Jethwani from W Health confirmed the development.
Chugh has been involved in more than four years and is considered one of the first members of W Health. Before joining W Health Ventures, he worked as a partner in Lok Capital (Akshayakalpa Organics and Minkfi), where he invested in sectors. He also worked with consulting companies such as Alvarez & Marsal and PWC in the past and focused on strategy and commercial status detection for private capital customers.
Chugh’s movement comes at a time when the venture capital ecosystem witnesses a confusion. Some senior fund managers act to establish their own initiatives, while others are looking for better headlines and payment.
In February, Peak XV’s executive directors Abheek Anand and Shailesh Lakhani left the venture capital company almost two years after breaking the ties with US partner Sequoia Capital.
In November last year, Shashank Ardev, the founding partner and partner of the 100.VC, stopped establishing its own initiative 247VC. Raj Dugar, the executive partner of Eight Roads Ventures, resigned after a 17 -year mission last year.
Lock Inferences
- W Health Ventures will close a $ 100 million fund II, which focuses on early health investments.
- The company aims to support initiatives with the company creation model by combining initiatives and incubation.
- Despite a challenging financing environment, W Health is determined to support innovative health solutions.
